Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Zag Bio Announces $80 Million Series A
Series AVenture Capital

Zag Bio Announces $80 Million Series A

•November 3, 2025
•Nov 3, 2025
0

Participants

Zag Bio

Zag Bio

company

Polaris Partners

Polaris Partners

investor

T1D Fund

T1D Fund

investor

Why It Matters

The sizable Series A underscores strong investor confidence and provides Zag Bio with the resources to fast‑track its therapeutic programs, potentially reshaping the diabetes treatment landscape and attracting further market interest.

Deal Summary

Zag Bio, a Cambridge‑based biotech startup, secured $80 million in a Series A financing round led by T1D Fund and Polaris Partners. The new capital will support the company’s product development and growth initiatives.

0

Comments

Want to join the conversation?

Loading comments...